3,579 results found

In August 2009, Pfizer settled a number of cases alleging FCA violations concerning several drugs, including an antipsychotic drug called Geodon.

In a decision issued on May 3, Judge Edward M. Chen of the U.S. District Court for the Northern District of California dismissed – with prejudice – the bulk of federal and California state wage and hour allegations made against Ropes & Gray client Adventures Rolling Cross-Country (ARCC), a California-based travel camp operator that provides international educational and adventure camp experiences for youths.

On August 9, 2017, the U.S. Department of Labor (the "DOL") filed a notice in connection with pending litigation that revealed a portion of its current plans for the fiduciary rule.

Ed Black, co-head of Ropes & Gray's IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.

On October 11, 2019, Governor Gavin Newsom signed into law five bills that directly amend the California Consumer Privacy Act (the "CCPA") – AB 25, AB 874, AB 1146, AB 1355 and AB 1564.

In taking action against TD Bank, N.A., for allegedly losing two unencrypted backup tapes, a group of attorneys general highlighted their increasing focus on encryption in data breach matters, as well as the need to promptly notify customers of the loss of their personal information.

China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").

China's Government will launch several incentives to enhance accessibility of innovative drugs, especially imported oncology drugs.

The China Food and Drug Administration (CFDA) has published its proposed amendment of the Medical Device Regulations (MDR), previously known as the State Council Order # 650, for public comments.

On November 21, 2014, China Food and Drug Administration ("CFDA") released a Draft Guidance on Multi-Regional Clinical Trials (Provisional) ("Guidance") for public comments through December 21.

Over the past few years, as the federal government has firmed its stance against intellectual property theft and foreign interference in scientific research, many in the U.S. research community have perceived a growing threat to scientific inquiry.

On February 17, 2016, the Spanish headquarters of the Industrial and Commercial Bank of China ("ICBC") were raided by Europol officers and Spanish law enforcement authorities...

The regulation will not require due diligence by manufacturers, importers and sellers of finished products and components.

Last month, the European Supervisory Authorities (EBA, ESMA and EIOPA – together, the ESAs) each recently published their Final Reports to the European Commission...

The unveiling of the EU tax haven blacklist was covered in our Alert dated 12 December, 2017.

On Wednesday, August 27, Ropes & Gray Litigation & Enforcement partner Alexander Simkin and associate Eileen Falk joined Sami Grover, Sustainability Communications Director at thinkPARALLAX...

The UK Government continues its efforts to boost investment in high growth companies across the country. A number of the UK's leading VC and growth equity firms...

As debt funds continue to expand their footprint in the European commercial real estate (CRE) market, the use of back-leverage – long established in the US – is increasingly...